Protective Effects of Nargenicin A1 against Tacrolimus-Induced Oxidative Stress in Hirame Natural Embryo Cells.
DNA damage
ROS
apoptosis
nargenicin A1
tacrolimus
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
22 03 2019
22 03 2019
Historique:
received:
16
02
2019
revised:
14
03
2019
accepted:
15
03
2019
entrez:
27
3
2019
pubmed:
27
3
2019
medline:
31
7
2019
Statut:
epublish
Résumé
Tacrolimus is widely used as an immunosuppressant to reduce the risk of rejection after organ transplantation, but its cytotoxicity is problematic. Nargenicin A1 is an antibiotic extracted from
Identifiants
pubmed: 30909475
pii: ijerph16061044
doi: 10.3390/ijerph16061044
pmc: PMC6466173
pii:
doi:
Substances chimiques
Immunosuppressive Agents
0
Lactones
0
nargenicin A1
70695-02-2
Tacrolimus
WM0HAQ4WNM
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Références
Apoptosis. 2007 May;12(5):803-13
pubmed: 17294081
Transplant Proc. 2018 May;50(4):1172-1177
pubmed: 29731088
Biochem Pharmacol. 2009 Jun 1;77(11):1694-701
pubmed: 19428323
Arch Pharm Res. 2008 Oct;31(10):1339-45
pubmed: 18958426
Transplant Proc. 2008 Oct;40(8):2734-6
pubmed: 18929848
Mol Endocrinol. 2011 Aug;25(8):1376-86
pubmed: 21622531
J Antibiot (Tokyo). 1982 Feb;35(2):254-5
pubmed: 7076571
Nat Rev Mol Cell Biol. 2007 Oct;8(10):813-24
pubmed: 17848967
Toxicol Res. 2017 Apr;33(2):107-118
pubmed: 28443181
Am J Chin Med. 2008;36(3):615-24
pubmed: 18543393
Antioxid Redox Signal. 2011 Feb 1;14(3):459-68
pubmed: 20649461
J Ginseng Res. 2018 Jan;42(1):75-80
pubmed: 29348725
Tumour Biol. 2016 Jul;37(7):8471-86
pubmed: 27059734
Neurol Res. 2004 Jun;26(4):371-80
pubmed: 15198862
Inflamm Res. 2006 Jun;55(6):228-35
pubmed: 16955241
Nutr Res Pract. 2018 Apr;12(2):129-134
pubmed: 29629029
Hum Exp Toxicol. 2010 Aug;29(8):627-33
pubmed: 20056734
Mol Cell Biochem. 2016 Jul;418(1-2):91-102
pubmed: 27344165
Lab Invest. 2017 Nov;97(11):1271-1281
pubmed: 28759009
Am J Transplant. 2013 Jul;13(7):1665-75
pubmed: 23651473
Nature. 2000 Nov 9;408(6809):239-47
pubmed: 11089981
Int Rev Cell Mol Biol. 2018;341:169-200
pubmed: 30262032
J Immunol. 2013 Dec 15;191(12):5785-91
pubmed: 24319282
Semin Cell Dev Biol. 2018 Aug;80:50-64
pubmed: 28587975
Transpl Int. 2012 Oct;25(10):e111-2
pubmed: 22909288
Arch Oral Biol. 2008 Aug;53(8):723-8
pubmed: 18342291
Transplant Proc. 1987 Oct;19(5 Suppl 6):11-6
pubmed: 2445067
Bratisl Lek Listy. 2016;117(6):358-62
pubmed: 27546370
Expert Opin Drug Saf. 2015 Oct;14(10):1531-46
pubmed: 26329325
Ageing Res Rev. 2013 Jan;12(1):376-90
pubmed: 23123177
FP Essent. 2016 Nov;450:22-27
pubmed: 27869439
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):389-400
pubmed: 26342319
Mol Med Rep. 2016 Nov;14(5):4124-4134
pubmed: 27633115
Cell Mol Life Sci. 2012 Jun;69(11):1787-97
pubmed: 22179840
Int J Environ Res Public Health. 2018 Jun 05;15(6):
pubmed: 29874784
Clin Transplant. 2017 Sep;31(9):
pubmed: 28621877
Expert Rev Clin Pharmacol. 2018 Jun;11(6):581-588
pubmed: 29779413
J Antibiot (Tokyo). 1985 Mar;38(3):423-6
pubmed: 4008333
Oxid Med Cell Longev. 2017;2017:8416763
pubmed: 28819546
Neuroreport. 2009 Jul 15;20(11):1007-12
pubmed: 19474767
Br J Clin Pharmacol. 1999 Sep;48(3):445-8
pubmed: 10510159
Exp Clin Transplant. 2012 Oct;10(5):439-45
pubmed: 22817282
Curr Pharm Des. 2014;20(35):5507-9
pubmed: 24606795
Transplantation. 2017 Dec;101(12):2862-2872
pubmed: 28885495
J Pharm Biomed Anal. 2016 Aug 5;127:207-31
pubmed: 26874932